Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies
Clinical trial NCT00460460 · TERMINATED
Trial details
- NCT number
- NCT00460460
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.